Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Non-cash Items: 2019-2025

Historic Non-cash Items for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $4.4 million.

  • Eton Pharmaceuticals' Non-cash Items fell 60.90% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 60.90%. This contributed to the annual value of $51.3 million for FY2024, which is 1325.05% up from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Non-cash Items stood at $4.4 million, which was down 91.90% from $54.0 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Non-cash Items ranged from a high of $54.0 million in Q2 2025 and a low of $437,000 during Q3 2022.
  • Moreover, its 3-year median value for Non-cash Items was $4.8 million (2023), whereas its average is $17.5 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Non-cash Items crashed by 94.07% in 2021 and then surged by 1,325.05% in 2024.
  • Eton Pharmaceuticals' Non-cash Items (Quarterly) stood at $2.7 million in 2021, then slumped by 35.92% to $437,000 in 2022, then skyrocketed by 618.48% to $3.6 million in 2023, then spiked by 1,325.05% to $51.3 million in 2024, then slumped by 60.90% to $4.4 million in 2025.
  • Its Non-cash Items stands at $4.4 million for Q3 2025, versus $54.0 million for Q2 2025 and $46.6 million for Q1 2025.